Publication | Open Access

Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer

Non-small-cell Lung CancerDna-pk OvercomesMedicineThird-generation Egfr-tki OsimertinibBronchial NeoplasmCancer BiologyTumor SuppressorCancer GeneticsRadiation OncologyOncologyCell BiologyLung CancerTumor Biology